Breast Pain While Receiving Hormone Replacement Therapy is Concerning

by C.H. Weaver M.D.

According to an article published in the Archives of Internal Medicine, postmenopausal women who experience new pain in their breasts while taking hormone replacement therapy may have an increased risk of developing breast cancer.

As women reach menopause and beyond, more than 80% will experience symptoms such as hot flashes, night sweats, sleep disturbance, and vaginal dryness. Postmenopausal hormone therapy that includes estrogen can relieve these symptoms, but the risks and benefits of hormone therapy must be carefully weighed for each woman.

Previous reports suggest that the combination of estrogen plus progestin, for example, increases the risk of breast cancer, heart disease, stroke, and blood clots, but decreases the risk of colorectal cancer and bone fractures.

Dense breast tissue is a risk factor for developing breast cancer. Women with the majority of their breasts comprised of dense breast tissue are at a significantly higher risk of developing breast cancer than women who do not have dense breast tissue.

Recommended Articles

Image placeholder title

Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted?

New precision medicines effectively target KRAS mutations in lung, colon, and other cancers.

Researchers from California recently analyzed data from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. This study included 594 women aged 45 to 64 years of age. Results from mammography scans were evaluated at the initiation of the trial, as well as at 12 months follow-up. Women were either treated with hormone replacement therapy or placebo (inactive substitute).

  • Women taking hormone replacement therapy with new onset breast pain had a nearly 4% increase in breast tissue density.
  • Women taking hormone replacement therapy who did not experience new breast pain had only a 0.6% increase in breast tissue density.

The researchers concluded that new onset breast pain while taking hormone replacement therapy is associated with an increase in breast tissue density. Since breast tissue density is associated with an increased risk of breast cancer, these results indicate that new onset breast pain may ultimately be associated with an increased risk of breast cancer among postmenopausal women taking hormone replacement therapy.

Women who are experiencing menopausal symptoms may wish to speak with their physician about their individual risks and benefits of taking hormone replacement therapy.

Reference: Crandall C, Karlamangla A, Huang M-H, et al. Association of New-Onset Breast Discomfort with an Increase in Mammographic Density During Hormone Therapy. Archives of Internal Medicine. 2006;166:1578-1584.